1. Aitken M, Berndt ER, Cutler DM (2009) Prescription drug spending trends in the United States: Looking beyond the turning point. Health Affairs 28:151–160
2. Almashat S, Wolfe SM, Carome M (2016) Twenty-Five Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015. https://www.citizen.org/sites/default/files/2311.pdf . Zugegriffen: 16. Febr. 2018
3. Angelmar R (2015) Marketing im Gesundheitssektor. In: Knaebel H-P, Wente M (Hrsg) Scientific Marketing in der Medizin. Gabler, Berlin, S 173–197
4. Arnold D, Troyer J (2016) Does increased spending on pharmaceutical marketing inhibit pioneering innovation?. Journal of Health Politics, Policy and Law 41:157–179
5. AWMF (2017) Frühe Nutzenbewertung neuer Arzneimittel in Deutschland 2011 – 2016, Analysen und Impulse. Berlin